Skip to main content

Table 2 The correlation between cytoplasmic FOXP1 expression and clinicopathological parameters in IDC cases

From: Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer

Clinicopathological parameters Cytoplasmic FOXP1 expression
Positive (%) n = 66 Negative (%) n = 17 P value
ER    0.030 a
 Positive 31 (47.0) 13 (76.5)  
 Negative 35 (53.0) 4 (23.5)  
HER2    0.443
 Positive 22 (33.3) 4 (23.5)  
 Negative 44 (66.7) 13 (76.5)  
Calpain II    0.007 a
 Positive 55 (83.3) 9 (52.9)  
 Negative 11 (16.7) 8 (47.1)  
pAKT    0.863
 Positive 48 (72.7) 12 (70.6)  
 Negative 18 (27.3) 5 (29.4)  
pmTOR    0.093
 Positive 52 (78.8) 10 (58.8)  
 Negative 14 (21.2) 7 (41.2)  
p4E-BP1    0.607
 Positive 47 (71.2) 11 (64.7)  
 Negative 19 (28.8) 6 (35.3)  
p-p70S6K    0.363
 Positive 50 (75.8) 11 (64.7)  
 Negative 16 (24.2) 6 (35.3)  
Stage    0.562
 Stage I 7 (10.6) 1 (5.9)  
 Stage II 38 (57.6) 13 (76.5)  
 Stage III 21 (31.8) 3 (17.6)  
Grade    0.325
 Grade I 16 (24.2) 3 (17.6)  
 Grade II 38 (57.6) 9 (52.9)  
 Grade III 12 (18.2) 5 (29.4)  
Nodal status    0.090
 Positive 49 (74.2) 9 (52.9)  
 Negative 17 (25.8) 8 (47.1)  
Distant metastasis    0.230
 Positive 26 (39.4) 4 (23.5)  
 Negative 40 (60.6) 13 (76.5)  
Tumor size    0.907
4 cm 30 (45.5) 8 (47.1)  
 > 4 cm 36 (54.5) 9 (52.9)  
Age    0.762
55 yrs 44 (66.7) 12 (70.6)  
 > 55 yrs 22 (33.3) 5 (29.4)  
  1. aStatistically significant p values are in bold